Rusconi C, Cheah CY, Eyre TA, Tucker DL, et al. Ibrutinib improves survival compared to chemotherapy in mantle cell lymphoma with central nervous system relapse. Blood 2022 Jul 5. pii: 485785. doi: 10.1182/blood.2022015560.
PMID: 35789260